Azaindole compounds for treatment of central nervous system disorders

Details for Australian Patent Application No. 2009225025 (hide)

Owner Merck Patent GmbH

Inventors Katzer, Michael; Heinrich, Timo

Agent Davies Collison Cave

Pub. Number AU-A-2009225025

PCT Pub. Number WO2009/112139

Priority 08004860.6 14.03.08 EP

Filing date 14 February 2009

Wipo publication date 17 September 2009

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4353 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

4 November 2010 PCT application entered the National Phase

  PCT publication WO2009/112139 Priority application(s): WO2009/112139

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009225027-Device and method for manipulating an audio signal having a transient event

2009225023-Metallurgical process and plant herefor